News

September 12, 2017

Transplant Recipients Account for 3% of non-Hodgkin Lymphoma Cases in Children, Study Finds

News

Nearly three out of every 100 cases of non-Hodgkin lymphoma in American children and adolescents occurs in those who received an organ transplant, a study reports. The research showed that ... Read more

September 11, 2017September 11, 2017

Advisory Agency Decision Will Make Lymphoma Therapy Adcetris More Accessible in UK

News

Britain’s national health service advisory agency has made a decision that will make Adcetris (brentuximab vedotin) more accessible as a treatment for an aggressive type of lymphoma. The National Institute for Health ... Read more

September 8, 2017September 10, 2017

FDA Places Holds on Imfinzi Trials Following Unexplained Deaths in Keytruda Trials

News

The U.S. Food and Drug Administration (FDA) has placed a partial hold on two clinical trials testing a combination of AstraZeneca‘s Imfinzi (durvalumab) with an immunomodulatory drug in lymphoma and leukemia ... Read more

September 7, 2017

Verastem, with Phase 3 Results, to Request FDA Approve Oral Duvelisib to Treat Advanced CLL and SLL

News

Verastem’s duvelisib was seen to outperform Arzerra (ofatumumab) in a Phase 3 trial of patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), the company ... Read more

September 5, 2017

FDA Approves Mylotarg for Adults and Children with AML

News

The U.S. Food and Drug Administration has approved Pfizer’s Mylotarg (gemtuzumab ozogamicin) for adults and children with acute myeloid leukemia (AML) whose cancer carries the CD33 marker. In adults, ... Read more

September 1, 2017

Lymphoma Patient’s Brain Tumor Disappeared After She Received JCAR017, Study Reports

News

Juno Therapeutics‘ immunotherapy JCAR017 eliminated a brain tumor in a patient whose lymphoma had spread to her brain, researchers at Massachusetts General Hospital Cancer Center reported. The team wrote about ... Read more

August 31, 2017September 1, 2017

FDA Approves First-Ever CAR T-Cell Therapy, Kymriah, for Young B-Cell ALL Patients

News

In what is described as a historical decision, the U.S. Food and Drug Administration (FDA) has approved the first gene therapy-based cancer treatment in the United States. The FDA ... Read more

August 30, 2017August 30, 2017

FDA to Review Gazyva as First-Line Treatment for Follicular Lymphoma

News

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental biologics license application (sBLA) seeking the approval of Gazyva (obinutuzumab) in combination with chemotherapy, followed by Gazyva alone, for patients with previously ... Read more

August 29, 2017August 29, 2017

Gilead to Become Cell Therapy Leader Once $11.9B Acquisition of Kite Pharma Closes

News

Just a few months before the U.S. Food and Drug Administration is expected to reach a decision on Kite Pharma‘s application seeking approval for its therapy axicabtagene ciloleucel (axi-cel) for the ... Read more

August 28, 2017August 28, 2017

FDA Grants Breakthrough Therapy Status to Lymphoma Treatment Poteligeo

News

The U.S. Food and Drug Administration has granted breakthrough therapy designation to Poteligeo (mogamulizumab) as a treatment for mycosis fungoides and sézary syndrome, the most common subtypes of cutaneous T-cell ... Read more